During the past decade, Davidorf Eye Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Davidorf Eye Group" are "Cataract" (1 trials), "Degeneration" (1 trials), "Ectasia" (1 trials), "Infectious Keratitis" (1 trials) and "Keratoconus" (1 trials). Many other conditions were trialed in "Davidorf Eye Group" in a lesser frequency.

Most popular intervention types in "Davidorf Eye Group" are "Device" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ciprofloxicin or Vigamox or other." (1 trials), "Nonsteroidal (Acular, Acuvail, Voltaren Xibrom, etc)" (1 trials), "Standard Monofocal Intraocular Lens" (1 trials), "Steroid (FML, Pred Forte, Flarex, etc.)" (1 trials) and "Synchrony® Dual Optic Intraocular Lens" (1 trials). Other intervention names were less common.

The vast majority of trials in "Davidorf Eye Group" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Davidorf Eye Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Davidorf Eye Group, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Davidorf Eye Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".